Core Scientific, Inc. (NASDAQ: CORZ) stock slid sharply on Tuesday, December 16, 2025, as investors digested fresh reporting tied to the company’s fast-growing AI data center business—plus a broader wobble in “AI infrastructure” sentiment that’s been hitting anything connected to big-ticket compute buildouts.
Shares of Core Scientific fell about 6.2% intraday to roughly $14.34, according to MarketBeat, with trading volume notably below the stock’s average daily pace—one of those days where the market isn’t just repricing, it’s rethinking. [1]
Below is what’s driving the move, what the latest forecasts and analyst price targets suggest, and the key milestones that could determine whether CORZ is a “temporary turbulence” story—or a deeper reset.
What happened to Core Scientific stock on December 16, 2025?
Core Scientific shares dropped as investors focused on project execution risk—specifically around a major Texas AI data center campus the company is building for CoreWeave.
A report summarized by The Miner Mag says heavy summer rains and winds in North Texas delayed construction by about 60 days at the ~260-megawatt Denton, Texas AI compute data campus Core Scientific is developing for CoreWeave. The report also says the delay pushed the expected completion date back by several months, and that CoreWeave plans to lease the capacity to OpenAI once the site is finished. [2]
In a market that’s already jittery about whether AI infrastructure spending will pay off on schedule, a delay like that doesn’t land as “normal construction risk.” It lands as: timeline risk, revenue timing risk, and credibility risk.
Why a Denton, Texas delay matters so much for CORZ stock
Core Scientific is no longer “just” a bitcoin miner to equity markets. It’s increasingly priced like a power-and-landlord-to-AI story—because the company has been pivoting toward high-density colocation (Core Scientific often calls it HDC; previously referred to as HPC hosting) alongside its digital asset mining operations. [3]
That pivot is tightly linked to CoreWeave.
Back in February 2025, Core Scientific and CoreWeave announced a $1.2 billion expansion at the Denton site, saying it expanded CoreWeave’s total contracted HPC infrastructure with Core Scientific to ~590 MW across six sites, and boosted total projected revenue to $10.2 billion over 12-year contract terms. [4]
Core Scientific has also highlighted a ramp plan: an investor presentation published in late October 2025 described being on track to energize 250 MW by the end of 2025 and reaching ~590 MW by early 2027 for the existing CoreWeave contracted capacity. [5]
So when Denton slips, investors immediately ask two uncomfortable questions:
- Is this a one-off schedule hiccup—or a sign the buildout timeline is getting harder?
- If AI customers are pressuring timelines, who eats the friction: the landlord, the tenant, or the financiers?
Core Scientific’s own materials have emphasized protective contract features—such as take-or-pay structure, fixed pricing with an annual escalator, and no unilateral termination by the customer—along with security interests/UCC filings on data center assets. That helps explain why analysts like the contracted-revenue story, but it doesn’t eliminate construction and commissioning risk. [6]
The AI infrastructure mood swing is adding pressure
The Denton delay story is also arriving during a rough patch for AI infrastructure stocks—especially CoreWeave, which is central to the Core Scientific narrative.
A Wall Street Journal report described a steep drop in CoreWeave’s shares amid AI “bubble” concerns, pointing to Denton delays (tied to weather and design revisions) and referencing the earlier failed $9 billion merger attempt between CoreWeave and Core Scientific as part of the confidence shock. [7]
Other same-day coverage of CoreWeave echoed the idea that investor confidence is being tested by high capex demands, leverage questions, and the risk that AI returns take longer than markets hoped. [8]
Even though Core Scientific and CoreWeave are separate public companies, markets often trade them as linked organisms: when the tenant’s story wobbles, the landlord’s multiple can wobble too—particularly when a large chunk of the landlord’s growth narrative is tied to that tenant’s expansion pace.
Core Scientific’s fundamentals: the latest earnings snapshot (Q3 2025)
Core Scientific’s most recent reported quarter (fiscal third quarter 2025, released October 24, 2025) shows a company mid-transition—where the AI colocation business is growing, but the legacy mining business still dominates revenue.
From Core Scientific’s Q3 2025 release:
- Total revenue:$81.1 million (down from $95.4 million in Q3 2024)
- Digital asset self-mining revenue:$57.4 million
- Digital asset hosted mining revenue:$8.7 million
- High-Density Colocation (HDC) revenue:$15.0 million (up from $10.3 million in Q3 2024)
- Capital expenditures:$244.5 million, with $196.4 million funded by CoreWeave under existing colocation service agreements
- Liquidity:$694.8 million (including cash and bitcoin, as reported) [9]
Zacks’ write-up of that quarter also noted the headline market dynamic: an EPS loss of $0.46 beat consensus expectations (loss of $0.85), while revenue missed consensus estimates. [10]
That mix—EPS beat, revenue miss—often fuels volatility in high-beta names. And MarketBeat lists CORZ with an unusually high beta (reflecting how violently it can move when sentiment shifts). [11]
The CoreWeave relationship: massive upside, real concentration risk
If you want the one-sentence bull case for Core Scientific stock, it’s this:
Core Scientific controls valuable power and purpose-built facilities, and it’s converting that footprint into long-duration, high-density AI colocation revenue.
The scale of the CoreWeave relationship is why the market cares so much about Denton:
- The February 2025 announcement framed the relationship as ~590 MW across six sites and $10.2 billion of projected revenue over 12-year terms. [12]
- Corporate materials have described the CoreWeave contract structure as take-or-pay with fixed pricing and contractual protections. [13]
But there’s a mirror-image bear case:
If a large portion of the growth plan depends on one hyperscaler-like customer’s timelines and capital intensity, then delays, redesigns, or a changing funding environment can ripple directly into CORZ valuation—even if the long-term contracts remain intact.
This is exactly why “project execution” has become a stock-moving topic.
Analyst forecasts for Core Scientific stock: price targets and ratings (as of Dec. 16, 2025)
Despite Tuesday’s selloff, the Street’s published targets still generally point to upside—though the dispersion between sources is a reminder that forecasting a volatile infrastructure-and-crypto hybrid is a dangerous sport.
MarketBeat consensus (22 analysts)
MarketBeat reports Core Scientific has a “Moderate Buy” consensus rating and an average 12-month price target of $22.39, with a high target of $34 and low target of $15. [14]
MarketBeat also lists multiple firms that had raised targets in recent months, including Cantor Fitzgerald ($26), HC Wainwright ($25), Craig Hallum ($27), and Bernstein ($24). [15]
StockAnalysis consensus (13 analysts)
StockAnalysis similarly shows a consensus “Buy” rating and an average price target around $22.42, with $15 low / $34 high, and notes price targets were last updated in early November 2025. [16]
Recent published target changes (examples)
- Investing.com reported Cantor Fitzgerald raised its target to $26 (from $18) while maintaining an overweight rating in October 2025. [17]
- Nasdaq syndicated a Fintel-based piece indicating an average one-year target estimate of $25.48 (with a wide range of targets cited). [18]
Important nuance: these targets are not “today’s price prediction machines.” They’re model outputs, and in CORZ’s case they can swing meaningfully with (1) AI colocation delivery timelines, (2) CoreWeave’s capex posture, and (3) bitcoin price/network dynamics.
Institutional and insider activity: who’s buying into the volatility?
One reason CORZ remains heavily watched is that large investors continue to circle it—even as day-to-day price swings look like a caffeinated seismograph.
- A Motley Fool report highlighted that VR Advisory Services acquired more than 1.2 million shares in Q3, adding roughly $21.7 million of U.S. equity exposure via a new position. [19]
- MarketBeat reported Castleark Management LLC acquired 448,020 shares (a stake valued around $7.65 million based on its filing summary). [20]
- MarketBeat also noted insider buying: director Eric Stanton Weiss purchased 5,000 shares at $21.50 in November (as summarized in its report). [21]
None of this guarantees anything, of course. But it does suggest CORZ is not being treated like a forgotten small-cap—it’s being treated like a high-conviction, high-volatility infrastructure wager.
The merger that wasn’t: why the CoreWeave deal still echoes in CORZ
CoreWeave and Core Scientific signed a definitive all-stock acquisition agreement in July 2025, but it did not close.
Core Scientific later announced that it terminated the merger agreement after shareholders did not approve the transaction, emphasizing it would remain a publicly traded company on Nasdaq under ticker CORZ. [22]
Reuters also reported the termination, describing it as the culmination of a months-long investor and proxy advisory fight over valuation and deal structure. [23]
That history matters today because:
- It keeps Core Scientific’s equity story “standalone,” meaning investors are directly exposed to execution and financing outcomes (good and bad).
- It reinforces that the CoreWeave relationship is commercially huge even without a corporate tie-up—so headlines about CoreWeave’s buildout can still spill into CORZ trading.
Key risks investors are watching right now
CORZ is the kind of stock where the risks aren’t hidden—they’re wearing neon clothing.
1) Construction schedules and commissioning
The Denton delay reporting is a reminder that even “contracted revenue” has timing risk when physical infrastructure is involved. [24]
2) Power availability and grid constraints (especially Texas)
Texas remains a magnet for data center expansion, but grid interconnection is getting crowded. ERCOT reported an unprecedented surge in large-load requests in 2025—an environment that can influence timelines, costs, and regulatory scrutiny for power-hungry projects. [25]
3) Crypto exposure doesn’t disappear just because AI is the new hotness
Core Scientific still reported the majority of Q3 2025 revenue from digital asset self-mining. [26]
And crypto volatility remains a macro factor: Reuters reported bitcoin briefly dipped below $90,000 in December amid broader risk jitters, also noting that Standard Chartered cut its end-2025 bitcoin expectation to $100,000 from $200,000. [27]
4) Capital intensity (even when customers fund portions)
Core Scientific’s Q3 2025 capex was large, though the company reported a significant portion was funded by CoreWeave under colocation agreements. Investors will keep tracking whether that funding cadence stays smooth as buildouts scale. [28]
What could move Core Scientific stock next?
For the rest of December 2025 and into early 2026, CORZ price action is likely to be driven less by “generic AI hype” and more by milestones.
Here are the catalysts markets will likely fixate on:
- Updated timeline clarity for the Denton, Texas campus and any knock-on effects to the broader ramp (even small slips can matter when expectations are tight). [29]
- Evidence of delivery against the 250 MW-by-end-of-2025 trajectory and the longer arc toward ~590 MW by early 2027 (as outlined in investor materials). [30]
- Proof that high-density colocation revenue can scale meaningfully beyond the $15.0 million reported in Q3 2025—because that’s the bridge from “promising pivot” to “financial transformation.” [31]
- Bitcoin price + network economics, because even a perfect AI execution story can get temporarily steamrolled if crypto markets wobble hard enough. [32]
Bottom line: CORZ is a “two-engine” stock—AI infrastructure + bitcoin mining—and both engines are volatile
On December 16, 2025, Core Scientific stock fell hard because the market is laser-focused on one thing: execution certainty for its AI data center buildout—especially projects tied to CoreWeave and OpenAI-linked capacity—and any signal that timelines are slipping. [33]
At the same time, analyst forecasts still generally imply upside from current levels, with many published price targets clustering in the low-to-mid $20s (with wide dispersion). [34]
That combination—big upside narratives plus real-world buildout friction—is exactly why CORZ trades the way it does: not like a sleepy utility, but like a high-voltage bet on the physical reality of the AI boom.
References
1. www.marketbeat.com, 2. theminermag.com, 3. investors.corescientific.com, 4. investors.corescientific.com, 5. www.marketscreener.com, 6. www.marketscreener.com, 7. www.wsj.com, 8. www.investors.com, 9. investors.corescientific.com, 10. www.nasdaq.com, 11. www.marketbeat.com, 12. investors.corescientific.com, 13. www.marketscreener.com, 14. www.marketbeat.com, 15. www.marketbeat.com, 16. stockanalysis.com, 17. www.investing.com, 18. www.nasdaq.com, 19. www.fool.com, 20. www.marketbeat.com, 21. www.marketbeat.com, 22. investors.corescientific.com, 23. www.reuters.com, 24. theminermag.com, 25. www.chron.com, 26. investors.corescientific.com, 27. www.reuters.com, 28. investors.corescientific.com, 29. theminermag.com, 30. www.marketscreener.com, 31. investors.corescientific.com, 32. www.reuters.com, 33. www.marketbeat.com, 34. www.marketbeat.com
